ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)

Conditions

• Acute Respiratory Distress Syndrome
• Extracorporeal Membrane Oxygenation

Eligibility Criteria

Sex

ALL

Age

14 Days - 20 Years

Healthy Volunteers

Not accepted

Interventions

• ECMO support — DEVICE
  ECMO prescribed by treating physicians for respiratory support in the setting of PARDS.
• PROSpect protocolized therapies — OTHER
  PROSpect is testing the impact of supine/prone positioning and conventional mechanical ventilation (CMV)/high-frequency oscillatory ventilation (HFOV) on clinical outcomes in 1,000 children with severe PARDS. PROSpect manages severe PARDS subjects using a protocol that reserves ECMO for protocol failure. The CMV group targets an exhaled tidal volume of 5-7mL/kg of ideal body weight and a peak inspiratory pressure \<28 cm of H2O. The positive end expiratory pressure (PEEP) and FiO2 are titrated by a PEEP-FiO2 titration grid. The HFOV group titrates the mean airway pressure to target a FiO2 \< 0.5 and a goal hemoglobin oxygen saturation of 88-92%. The frequency is titrated between 8-12 Hz and amplitude from 60-90 to achieve a goal pH of 7.15-7.30. Ventilation protocols are implemented until 28 days or extubation. Children randomized to the prone positioning will remain prone for at least 16 consecutive hours per day. Children randomized to supine positioning group remain supine.

Study Details

ASCEND researchers are partnering with families of children who receive extracorporeal membrane oxygenation (ECMO) after a sudden failure of breathing named pediatric acute respiratory distress syndrome (PARDS). ECMO is a life support technology that uses an artificial lung outside of the body to do the lung's work. ASCEND has two objectives. The first objective is to learn more about children's abilities and quality of life among ECMO-supported children in the year after they leave the pediatric intensive care unit. The second objective is to compare short and long-term patient outcomes in two groups of children: one group managed with a mechanical ventilation protocol that reserves the use of extracorporeal membrane oxygenation (ECMO) until protocol failure to another group supported on ECMO per usual care.

Key Dates

Start date

Feb 4, 2021

Status verified

Dec 2025

Primary completion

Sep 30, 2027

Completion

Sep 30, 2027

Study Design

Enrollment

550 participants (estimated)

Arms

• Arm: Usual care ECMO Cohort
  The cohort will be comprised of 550 patients, aged 14 days to 20 years, who go on extracorporeal membrane oxygenation (ECMO) support due to pediatric acute respiratory distress syndrome (PARDS) at physician discretion. Patients with qualifying PARDS must have one oxygenation index (OI) ≥ 16 or two OIs 12 ≥ to \< 16 (at least 4 hours apart) or two oxygenation saturation indexes (OSIs) ≥ 10 (at least 4 hours apart) or one OI 12 ≥ to \< 16 and one OSI \> 10 (at least 4 hours apart) Subjects must be on mechanical ventilation for less than 240 hours (10 days) prior to cannulation. These measures must be after endotracheal intubation and before ECMO start. Chest radiograph prior to ECMO must show bilateral lung disease. Subjects cannulated on ECMO for no more than 96 hours prior to gaining consent.
• Arm: PROSpect protocolized therapies cohort
  The cohort will be comprised of 1000 patients, aged 14 days to 20 years, who are endotracheally intubated for PARDS. Patients with qualifying PARDS must have one oxygenation index (OI) ≥ 16 or two OIs 12 ≥ to \< 16 (at least 4 hours apart) or two oxygenation saturation indexes (OSIs) ≥ 10 (at least 4 hours apart) or one OI 12 ≥ to \< 16 and one OSI \> 10 (at least 4 hours apart). These measures must be after endotracheal intubation. Chest radiograph must show bilateral lung disease. Patient must be enrolled in a clinical trial Prone and Oscillation Pediatric Clinical Trial (PROSpect) NCT01515787 which is distinct from ASCEND. PROSpect is a response adaptive randomized clinical trial, testing the impact of supine/prone positioning and conventional mechanical ventilation/high-frequency oscillatory ventilation on short and long-term clinical outcomes in children with severe PARDS. PROSpect manages severe PARDS subjects using a rigorous protocol that reserves ECMO for protocol failure.

Primary Outcome Measure

Change in functional status [ Time Frame: baseline and 1 year after pediatric intensive care unit discharge ]

Central Contacts

• Kelli McDonough, MS
  734-232-1998
  [email protected]

Locations (76)

Find similar trials in Birmingham, AL

Related Studies

• The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
  Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York
• Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q System
  Enrolling By Invitation · Emory University · Atlanta, Georgia
• The Medical Management in Patients Exposed to Weapons of Mass Destruction
  Enrolling By Invitation · St. Justine's Hospital · College Park, Maryland
• Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
  PHASE2 · Recruiting · Vasomune Therapeutics, Inc. · Newport Beach, California